abnorm fattyacid composit plasmalipid cystic fibrosi primari secondari defect percentag fattyacid composit variou plasmalipid fraction cysticfibrosi patient without pancreat insuffici oblig heterozygot normal subject wa determin onli cysticfibrosi patient pancreat insuffici significantli abnorm fattyacid composit thi gener observ correl vitamin defici age sex sever diseas thu alter fattyacid composit differ plasmalipid fraction appear secondari consequ pancreat insuffici commonli associ cystic fibrosi direct metabol defect relat cysticfibrosi gene